- Home
- HL vs INSP Comparison
HL vs INSP Comparison
Compare HL & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HL
- INSP
- Stock Information
- Founded
- HL 1891
- INSP 2007
- Country
- HL United States
- INSP United States
- Employees
- HL N/A
- INSP N/A
- Industry
- HL Precious Metals
- INSP Medical/Dental Instruments
- Sector
- HL Basic Materials
- INSP Health Care
- Exchange
- HL Nasdaq
- INSP Nasdaq
- Market Cap
- HL 3.9B
- INSP 3.8B
- IPO Year
- HL N/A
- INSP 2018
- Fundamental
- Price
- HL $12.53
- INSP $75.17
- Analyst Decision
- HL Hold
- INSP Buy
- Analyst Count
- HL 5
- INSP 16
- Target Price
- HL $9.00
- INSP $147.07
- AVG Volume (30 Days)
- HL 18.7M
- INSP 936.1K
- Earning Date
- HL 11-05-2025
- INSP 11-03-2025
- Dividend Yield
- HL 0.12%
- INSP N/A
- EPS Growth
- HL N/A
- INSP 756.73
- EPS
- HL 0.16
- INSP 1.74
- Revenue
- HL $1,060,106,000.00
- INSP $861,312,000.00
- Revenue This Year
- HL $16.78
- INSP $14.83
- Revenue Next Year
- HL $2.30
- INSP $14.44
- P/E Ratio
- HL $79.13
- INSP $43.14
- Revenue Growth
- HL 36.30
- INSP 22.05
- 52 Week Low
- HL $4.46
- INSP $70.77
- 52 Week High
- HL $15.44
- INSP $216.01
- Technical
- Relative Strength Index (RSI)
- HL 51.08
- INSP 41.03
- Support Level
- HL $12.02
- INSP $75.64
- Resistance Level
- HL $13.35
- INSP $84.23
- Average True Range (ATR)
- HL 0.77
- INSP 3.16
- MACD
- HL -0.29
- INSP 0.12
- Stochastic Oscillator
- HL 14.91
- INSP 8.67
About HL Hecla Mining Company
Hecla Mining Co produces and explores silver, gold, zinc, and other metals. The operating business segments are Greens Creek, Lucky Friday, Keno Hill, and Casa Berardi. It generates maximum revenue from the Greens Creek segment. Geographically, It operates in Canada, the United States, and Mexico, and it derives a majority of its revenue from the United States.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.